CSL Limited announced it is collaborating with Walter and Eliza Hall Institute for Medical Research, one of the most prominent medical research and medicine development organizations in Australia, to create a Centre for Biologic Therapies. The new Centre combines WEHI's expertise in immunology, cancer, inflammatory disorders, and infectious diseases with CSL's world-class human antibody library and experience in biologic medicine discovery and development. The Centre will provide access to expert biologic discovery and optimization capabilities accelerating medicine development into the clinic, ultimately addressing a current gap in Australian medical research. Biologics are made in living systems and encompass a wide range of therapies including monoclonal antibodies, vaccines, growth factors and cell therapies. Based at WEHI, the Centre aims to generate high-quality and clinic-ready therapeutic antibodies against novel targets in human disease. The partners will contribute equally to the funding of the Centre with a combined investment of approximately $10 million over five years.